0 upcoming · 0 decided or due

PDUFA Calendar: FDA Decision Dates

Every date below links to the company filing that states it and quotes the sentence it was read from. When the date passes, the outcome is recorded from Drugs@FDA or the company's own filing. Nothing here is recalled or estimated.

Upcoming FDA decisions

No upcoming action date has been read from a company filing yet. The tracker searches SEC filings on a daily schedule, and each date it finds is published, with a link to the filing, once a person has reviewed it. Until then this list stays empty rather than filled from memory.

Upcoming FDA advisory committee meetings

Each from the notice FDA must publish in the Federal Register. A committee recommends; the FDA decides, usually by the PDUFA date.

No upcoming meeting has been read from a Federal Register notice yet. Notices are checked on the same daily schedule as company filings, and each meeting is listed with a link to its notice once reviewed.

How each date gets here

  1. On a daily schedule, SEC full-text search is queried for 8-K filings that mention a PDUFA or target action date. New dates are published after a person reviews them.
  2. The date is read from the filing text, together with the sentence that states it. A date earlier than the filing itself describes a decision already made and is ignored.
  3. If the filing does not name the drug in that sentence or the one before it, the date is held for a person to check rather than guessed.
  4. A later filing that states a new date for the same drug replaces the old one, which stays on the decision's page.
  5. After the date, Drugs@FDA and the company's filings are checked for the outcome.

See the methodology. Trial readouts and other catalysts are on the catalyst calendar.

15 reported dates are withheld

We know of 15 further FDA decision dates that we have not traced to the filing announcing them. Until that document is found the date is a lead, not a fact, and it is not listed. Other calendars list them; that is why this one is shorter.

What is a PDUFA date?

A PDUFA date (Prescription Drug User Fee Act) is the goal date by which the FDA has committed to act on a new drug application (NDA) or biologics license application (BLA). The action is binary: an approval, or a Complete Response Letter setting out what the application still needs.

Before the act passed in 1992, the FDA had no deadline for reviewing applications. Sponsors now pay a user fee, and in exchange the FDA commits to review timelines: about ten months from acceptance for a standard review and six for a priority review.

The date is announced by the company after the FDA accepts the filing, usually in a press release or an 8-K. Between acceptance and the date, the FDA may ask for more information, convene an advisory committee, or extend the review by three months after a major amendment. The company announces each of those too, which is why every date here links to the filing it came from.

More detail: PDUFA dates explained.

Frequently asked questions

What is a PDUFA date?+

A PDUFA (Prescription Drug User Fee Act) date is the goal date by which the FDA has committed to act on a new drug or biologics application. The action is either an approval or a Complete Response Letter (CRL) explaining what the application still needs. The review clock is set when the FDA accepts the application: about ten months for a standard review and six for a priority review.

Where do these dates come from?+

From the company. The FDA does not publish pending action dates; the sponsor discloses its date in an 8-K or press release after the FDA accepts the application. Every date on this page links to that filing and quotes the clause the date was read from. A date we have heard of but cannot trace to a filing is withheld, and the page says how many.

How do you know the outcome of a past decision?+

From Drugs@FDA, which records the approval date of each approved submission, or from the sponsor’s own 8-K reporting an approval or a complete response letter. If neither has appeared, the decision is listed as "date passed, outcome not yet found" rather than guessed. Gene and cell therapies and vaccines are regulated by CBER and do not appear in Drugs@FDA, so for those the company filing is the only source.

Can a PDUFA date move?+

Yes. The most common reason is a major amendment to the application during review, which lets the FDA extend the goal date by three months. A company announces an extension in a new filing; when that happens the new date replaces the old one here and the decision is marked as moved, with the earlier date kept on its page.

Is this calendar complete?+

No, and it says so. It lists every action date we have found stated in a company filing. Some sponsors disclose a date only in a press release that is not filed with the SEC, and private companies file nothing. Those dates are missing here until someone adds the source.

Is this investment advice?+

No. This is a record of what companies have disclosed and what the FDA has done, for education. A PDUFA date is a scheduled regulatory event, not a prediction of the outcome. Read the filing, and consider a licensed adviser before trading around any binary event.

Get the week's FDA decision dates by email

A free weekly briefing: the sourced FDA dates and trial readouts in the week ahead.

Subscribe free →